Lam Research (LRCX) shares fell 9% after the chipmaking equipment supplier's December-quarter outlook failed to meet high investor expectations, with analysts seeing supply constraints limiting its ...
Asianet Newsable on MSN
Meta's Muse AI momentum wins over analysts — but $140B spending outlook raises funding questions
UBS, Citi and Barclays see upside from Meta's emerging AI products, while Wells Fargo, Piper Sandler and TD Cowen flag ...
Learn more Abbott Laboratories (ABT) has an average rating of overweight and mean price target of $119.64, according to analysts polled by FactSet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results